Showing results (211-220 of 299) with videos related to
Sort By:
Pageof 30
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 2017
Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral TherapyChao Wang, Maria I Edilova, Lisa E Wagar, et al.The Journal of Infectious Diseases|March 4, 2014
Low proportions of CD28- CD8+ T cells expressing CD57 can be reversed by early ART initiation and predict mortality in treated HIV infectionSulggi A Lee, Elizabeth Sinclair, Vivek Jain, et al.The Journal of Infectious Diseases|January 29, 2003
Interleukin-2 Increases CD4+ lymphocyte numbers but does not enhance responses to immunization: results of A5046sHernan Valdez, Ronald Mitsuyasu, Alan Landay, et al.Plos One|February 1, 2012
Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionMaura Manion, Benigno Rodriguez, Kathleen Medvik, et al.AIDS (London, England)|February 26, 2021
Markers of inflammation and immune activation are associated with lung function in a multi-center cohort of persons with HIVAmanda K Jan, Julia V Moore, Richard J Wang, et al.AIDS (London, England)|February 27, 2024
Systemic inflammation in pregnant women with HIV: relationship with HIV treatment regimen and preterm deliveryRupak Shivakoti, Mark J Giganti, Michael M Lederman, et al.Frontiers in Immunology|May 2, 2019
Altered Lipidome Composition Is Related to Markers of Monocyte and Immune Activation in Antiretroviral Therapy Treated Human Immunodeficiency Virus (HIV) Infection and in Uninfected PersonsEmily R Bowman, Manjusha Kulkarni, Janelle Gabriel, et al.The Journal of Infectious Diseases|October 6, 2005
Distinct mechanisms of T cell reconstitution can be identified by estimating thymic volume in adult HIV-1 diseaseRobert C Kalayjian, John Spritzler, Minya Pu, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2004
Daily low-dose subcutaneous interleukin-2 added to single- or dual-nucleoside therapy in HIV infection does not protect against CD4+ T-cell decline or improve other indices of immune function: results of a randomized controlled clinical trial (ACTG 248)Mary A Vogler, Hedy Teppler, Rebecca Gelman, et al.Journal of Virology|July 25, 2014
Plasmacytoid dendritic cells mediate synergistic effects of HIV and lipopolysaccharide on CD27+ IgD- memory B cell apoptosisLumin Zhang, Zhenwu Luo, Scott F Sieg, et al.Pageof 30